Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology

C Domingues, A Santos, C Alvarez-Lorenzo… - ACS …, 2022 - ACS Publications
Worldwide nanotechnology development and application have fueled many scientific
advances, but technophilic expectations and technophobic demands must be …

[HTML][HTML] Exosome nanovesicles: a potential carrier for therapeutic delivery

VP Chavda, A Pandya, L Kumar, N Raval, LK Vora… - Nano Today, 2023 - Elsevier
Exosomes are small nanosized biovesicles that form when multivesicular bodies and the
plasma membrane fuse and are released into the surrounding body fluids. They are best …

Aptamer–Protein Interactions: From Regulation to Biomolecular Detection

C Ji, J Wei, L Zhang, X Hou, J Tan, Q Yuan… - Chemical …, 2023 - ACS Publications
Serving as the basis of cell life, interactions between nucleic acids and proteins play
essential roles in fundamental cellular processes. Aptamers are unique single-stranded …

Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models

D Singh, M Gupta, M Sarwat, HR Siddique - Critical reviews in oncology …, 2022 - Elsevier
Background Apigenin is being increasingly recognized as a cancer chemopreventive agent.
We aimed to investigate the anticancer effects of Apigenin in in-vivo studies to know its …

Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment

N Pandey, P Anastasiadis, CP Carney… - Advanced Drug Delivery …, 2022 - Elsevier
Glioblastoma (GBM) is the most common malignant adult brain cancer with no curative
treatment strategy. A significant hurdle in GBM treatment is effective therapeutic delivery to …

siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review

S Sargazi, R Arshad, R Ghamari… - Cell Biology …, 2022 - Wiley Online Library
Immune‐mediated diseases (IMDs) are chronic conditions that have an immune‐mediated
etiology. Clinically, these diseases appear to be unrelated, but pathogenic pathways have …

[HTML][HTML] Inorganic nanoparticles in bone healing applications

AC Burdușel, O Gherasim, E Andronescu… - Pharmaceutics, 2022 - mdpi.com
Modern biomedicine aims to develop integrated solutions that use medical,
biotechnological, materials science, and engineering concepts to create functional …

[HTML][HTML] CD133-functionalized gold nanoparticles as a carrier platform for telaglenastat (CB-839) against tumor stem cells

E Poonaki, AC Nickel, M Shafiee Ardestani… - International journal of …, 2022 - mdpi.com
The failure of a long-lasting curative therapeutic benefit of currently applied chemotherapies
against malignant cancers is suggested to be caused by the ineffectiveness of such …

[HTML][HTML] Accentuating CircRNA-miRNA-transcription factors axis: a conundrum in cancer research

D Singh, P Kesharwani, NA Alhakamy… - Frontiers in …, 2022 - frontiersin.org
Circular RNAs (circRNAs) are the newly uncovered class of non-coding RNAs being
cognized as profound regulators of gene expression in developmental and disease biology …

Protective effect of green synthesized Selenium Nanoparticles against Doxorubicin induced multiple adverse effects in Swiss albino mice

MA Khan, D Singh, A Arif, KK Sodhi, DK Singh… - Life Sciences, 2022 - Elsevier
Aims Doxorubicin (DOX) is a widely used drug against multiple cancers. However, its clinical
Use is often restricted due to multiple adverse effects. Recently, Selenium Nanoparticles …